Such a shift was also accompanied by increased levels of GFAP and Aβ, which suggests that glial activation and changes in APP isoforms are upstream events leading to AD pathology [50], and is partially recapitulated in this model. This evidence concerns the gene GFAP and Alzheimer disease.